
Vijay Pande
Founder, General Partner and Managing Partner, BioHealth at a16z
Founder, GP, & Managing Partner of a16z bio+health. Founder, Folding@home. Investor, Scientist, Engineer, Founder. AI, Bio, everything in between. https://t.co/X4mRNyio9S
Articles
-
Jan 14, 2025 |
a16z.com | Vijay Pande |Daisy Wolf |Bryan Kim |Zach Cohen
Today, we’re proud to announce we’ve led the Series A for Slingshot, the world’s first foundation model for psychology. This brings the total capital raised for the company to $40 million. Mental health has never been worse. While modern life is better than historical times on most dimensions, we’re increasingly lonely, sad, and anxious. Half of the world’s population will develop a mental health disorder in their lifetime.
-
Jan 13, 2025 |
crazystupidtech.com | Fred Vogelstein |Vijay Pande
By Fred VogelsteinWhen you talk to Jakob Uszkoreit you have to bring your “A“ game. It's not because he's evasive. It's because the stuff he's working on is cutting edge enough that you need every neuron firing to keep up with what he's talking about. Uszkoreit is one of the fathers of modern AI. In 2017 he was one of eight authors of Attention is All You Need, known to many as the Transformer paper.
-
Jan 10, 2025 |
a16z.com | Julie Yoo |Daisy Wolf |Vijay Pande
Andreessen Horowitz (a16z) Bio + Health today announced a newly formed, first-of-its-kind venture capital fund to fuel broader innovation in human health, in partnership with Eli Lilly and Company (“Lilly”). The Biotech Ecosystem Venture Fund (“Fund”) seeks to drive transformative progress in healthcare by investing in therapeutic platforms and cutting-edge technology companies that can bring new medicines and disease treatments to improve patients’ lives.
-
Oct 26, 2024 |
vijaypande.substack.com | Vijay Pande
It’s perplexing: How can the United States, with its renowned doctors, cutting-edge medical technology, and highest per capita healthcare spending, still see such disappointing health outcomes? At first glance, it doesn’t make sense. But upon closer examination, this is precisely the issue with the U.S. healthcare system. The answer is simpler than it seems. The system is excellent at treating diseases but fails to prioritize preventing them.
-
Oct 25, 2024 |
vijaypande.substack.com | Vijay Pande
\There’s a fascinating trick you can do with a bottle of water. If you let it cool in the freezer but remove it just before it freezes, the water stays in a liquid state even though it’s below freezing temperature. Then, with a simple tap or by adding a small piece of ice, the entire bottle rapidly solidifies before your eyes.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 32K
- Tweets
- 5K
- DMs Open
- No

🎯

“We're ingrained in stupidity… we have to do better.” @EricTopol, Director of the @scrippsresearch Translational Institute, doesn’t hold back in this conversation with @vijaypande, @a16z general partner, about superagers—those rare individuals who avoid chronic disease and https://t.co/kBeSeXPUss

🤔 Training humanoid robots in hand to hand combat. What could go wrong?

“Mecha Combat Arena” will be broadcast live on Chinese national TV channels on May 25th at 8:30 PM China time. https://t.co/kXzgmCY7yD

Interesting to consider AI in this context. Agree @JTLonsdale right now AI is vaguely midwit-y. Getting AI to the next stage (IQ ~140) will yield immediate impact on translating the smartest (IQ ~150+) of people for the rest of the world. https://t.co/WMMGyNI29S

AI is currently very similar to my 115 IQ acquaintances- confidently opining incorrectly on politics, history, and econ with default lefty-conventional mindsets. It will be interesting to watch if we can get it up to 150 IQ and it learns to discern and apply higher-order logic.